Skip To Main Content
Hellen C Barsosio on Muck Rack

Hellen C Barsosio

As seen in: MDPI, The Lancet
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Hellen C

Contact Hellen C, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Chemoprevention for malaria with monthly intermittent preventive treatment with dihydroartemisinin-piperaquine in pregnant women living with HIV on daily co-trimoxazole in Kenya and Malawi: a randomised, double-blind, placebo-controlled trial - The Lancet

|
By Hellen C Barsosio, Mwayiwawo Madanitsa, Everlyne D Ondieki, James Dodd
| The Lancet Verified
Research in context Evidence before this study In October, 2017, the WHO Malaria Policy Advisory Committee (MPAC) noted that daily unsupervised co-trimoxazole provided only partial protection against malaria for pregnant women living with HIV in areas with high-grade antifolate resistance.
Open in Who Shared Issue with article?

Effect of monthly intermittent preventive treatment with dihydroartemisinin-piperaquine with and without azithromycin versus monthly sulfadoxine-pyrimethamine on adverse pregnancy outcomes in Africa: a double-blind randomised, partly placebo-controlled tr

|
By Mwayiwawo Madanitsa, Hellen C Barsosio, George Mtove, Reginald A Kavishe
| The Lancet Verified
Summary Background Intermittent preventive treatment in pregnancy (IPTp) with dihydroartemisinin–piperaquine is more effective than IPTp with sulfadoxine–pyrimethamine at reducing malaria infection during pregnancy in areas with high-grade resistance to sulfadoxine–pyrimethamine by Plasmodium falciparum in east Africa.
Open in Who Shared Issue with article?

Effect of monthly intermittent preventive treatment with dihydroartemisinin-piperaquine with and without azithromycin versus monthly sulfadoxine-pyrimethamine on adverse pregnancy outcomes in Africa: a double-blind randomised, partly placebo-controlled tr

|
By Mwayiwawo Madanitsa, Hellen C Barsosio, George Mtove, Reginald A Kavishe
| The Lancet Verified
Summary Background Intermittent preventive treatment in pregnancy (IPTp) with dihydroartemisinin–piperaquine is more effective than IPTp with sulfadoxine–pyrimethamine at reducing malaria infection during pregnancy in areas with high-grade resistance to sulfadoxine–pyrimethamine by Plasmodium falciparum in east Africa.
Open in Who Shared Issue with article?
See all 3 licensed articles (4 Total)